RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Respiratory Distress Syndrome - Pipeline Review, Q1 2011
Jan 2011 - 22 pages - $500
Acute Respiratory Distress Syndrome - Pipeline Review, Q1 2011
Mar 2011 - 28 pages - $500
Neonatal Respiratory Distress Syndrome - Pipeline Review, Q2 2011
Jun 2011 - 34 pages - $500
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2011
Oct 2011 - 60 pages - $500
Adult Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010
Dec 2010 - 36 pages - $1,000
Respiratory Distress Syndrome - Pipeline Review, Q3 2011
Jul 2011 - 92 pages - $500
ORG Informatics Limited (517195) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $125
Acute Respiratory Distress Syndrome (ARDS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jun 2011 - 62 pages - $2,000
Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, Q1, 2011
Jan 2011 - 37 pages - $1,000
CREDIT ORG OF S&M ENTPRS (8489) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
More Related Market Research Reports >>>

Your selection

Industry sector
Non-profit org./Government del
Legal del
Therapeutic target
Respiratory del
Meconium aspiration syndrome del
Year
2003 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us